A novel missense mutation in the homeodomain of the hepatocyte nuclear factor-1α/maturity-onset diabetes of the young 3 in a Japanese early-onset type 2 diabetic patient and time-course of glucose-stimulated insulin secretion

被引：12
|
作者：
Awata, T
Kurihara, S
Inoue, K
Inoue, I
Takei, S
Ishii, C
Negishi, K
Namai, K
Kanazawa, Y
Kuzuya, T
Katayama, S
机构：
[1] Saitama Med Sch, Dept Internal Med 4, Moroyama, Saitama 3500495, Japan
[2] Jichi Med Sch, Omiya Med Ctr, Omiya, Saitama, Japan
来源：
DIABETES CARE | 1998年 / 21卷 / 09期
关键词：
D O I：
10.2337/diacare.21.9.1569
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1569 / 1571
页数：3
相关论文
共 50 条
  • [21] A Family with a Novel Termination Mutation in Hepatic Nuclear Factor 1α in Maturity-Onset Diabetes of the Young Type 3 Which Is Unresponsive to Sulphonylurea Therapy
    Demol, S.
    Lebenthal, Y.
    Bar-Meisels, M.
    Phillip, M.
    Gat-Yablonski, G.
    Gozlan, Y.
    HORMONE RESEARCH IN PAEDIATRICS, 2014, 81 (04): : 280 - 284
  • [22] Mutations in the hepatocyte nuclear factor-1α gene (MODY3) are not a major cause of early-onset non-insulin-dependent (type 2) diabetes mellitus in Japanese
    Nishigori, H
    Yamada, S
    Kohama, T
    Utsugi, T
    Shimizu, H
    Takeuchi, T
    Takeda, J
    JOURNAL OF HUMAN GENETICS, 1998, 43 (02) : 107 - 110
  • [23] Mutations in the hepatocyte nuclear factor-1α gene (MODY3) are not a major cause of early-onset non-insulin-dependent (type 2) diabetes mellitus in Japanese
    Hidekazu Nishigori
    Shirou Yamada
    Tomoko Kohama
    Toshihiro Utsugi
    Hiroyuki Shimizu
    Toshiyuki Takeuchi
    J. Takeda
    Journal of Human Genetics, 1998, 43 : 107 - 110
  • [24] Large genomic Rearrangements in the hepatocyte nuclear factor-1β (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5
    Bellanné-Chantelot, C
    Clauin, S
    Chauveau, D
    Collin, P
    Daumont, M
    Douillard, C
    Dubois-Laforgue, D
    Dusselier, L
    Gautier, JF
    Jadoul, M
    Laloi-Michelin, M
    Jacquesson, L
    Larger, E
    Louis, J
    Nicolino, M
    Subra, JF
    Wilhem, JM
    Young, J
    Velho, G
    Timsit, J
    DIABETES, 2005, 54 (11) : 3126 - 3132
  • [25] Hepatocyte nuclear factor-1α gene inactivation:: Cosegregation between liver adenomatosis and diabetes phenotypes in two maturity-onset diabetes of the young (MODY)3 families
    Reznik, Y
    Dao, T
    Coutant, R
    Chiche, L
    Jeannot, E
    Clauin, S
    Rousselot, P
    Fabre, M
    Oberti, F
    Fatome, A
    Zucman-Rossi, J
    Bellanne-Chantelot, C
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (03): : 1476 - 1480
  • [26] A novel hepatocyte nuclear factor-1β (MODY-5) gene mutation in an Italian family with renal dysfunctions and early-onset diabetes
    Carbone, I
    Cotellessa, M
    Barella, C
    Minetti, C
    Ghiggeri, GM
    Caridi, G
    Perfumo, F
    Lorini, R
    DIABETOLOGIA, 2002, 45 (01) : 153 - 154
  • [27] A novel hepatocyte nuclear factor-1β (MODY-5) gene mutation in an Italian family with renal dysfunctions and early-onset diabetes
    Diabetologia, 2002, 45 (1) : 153 - 154
  • [28] Identification of nine novel mutations in the hepatocyte nuclear factor 1 alpha gene associated with maturity-onset diabetes of the young (MODY3)
    Vaxillaire, M
    Rouard, M
    Yamagata, K
    Oda, N
    Kaisaki, PJ
    Boriraj, VV
    Chevre, JC
    Boccio, V
    Cox, RD
    Lathrop, GM
    Dussoix, P
    Philippe, J
    Timsit, J
    Charpentier, G
    Velho, G
    Bell, GI
    Froguel, P
    HUMAN MOLECULAR GENETICS, 1997, 6 (04) : 583 - 586
  • [29] Exonic duplication of the Hepatocyte Nuclear Factor-1β gene (transcription factor 2, hepatic) as a cause of maturity onset diabetes of the young type 5
    Carette, Claire
    Vaury, Christelle
    Barthelemy, Anne
    Clauin, Severine
    Gruenfeld, Jean-Pierre
    Timsit, Jose
    Bellanne-Chantelot, Christine
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (07): : 2844 - 2847
  • [30] Hepatocyte nuclear factor-4α involved in type 1 maturity-onset diabetes of the young is a novel target of AMP-activated protein kinase
    Leclerc, I
    Lenzner, C
    Gourdon, L
    Vaulont, S
    Kahn, A
    Viollet, B
    DIABETES, 2001, 50 (07) : 1515 - 1521
12345